225 related articles for article (PubMed ID: 1426029)
1. Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells.
Miki I; Kase H; Ishii A
Eur J Pharmacol; 1992 Oct; 227(2):199-204. PubMed ID: 1426029
[TBL] [Abstract][Full Text] [Related]
2. Characterization of thromboxane A2/prostaglandin H2 receptors and histamine H1 receptors in cultured guinea-pig tracheal smooth-muscle cells.
Miki I; Nonaka H; Ishii A
Biochim Biophys Acta; 1992 Oct; 1137(1):107-15. PubMed ID: 1356444
[TBL] [Abstract][Full Text] [Related]
3. Effects of KW-3635, a novel dibenzoxepin derivative of a selective thromboxane A2 antagonist, on human, guinea pig and rat platelets.
Miki I; Kishibayashi N; Nonaka H; Ohshima E; Takami H; Obase H; Ishii A
Jpn J Pharmacol; 1992 Jul; 59(3):357-64. PubMed ID: 1434130
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
Furci L; Fitzgerald DJ; Fitzgerald GA
J Pharmacol Exp Ther; 1991 Jul; 258(1):74-81. PubMed ID: 1830100
[TBL] [Abstract][Full Text] [Related]
5. Identification of functional PGH2/TxA2 receptors on human endothelial cells.
Kent KC; Collins LJ; Schwerin FT; Raychowdhury MK; Ware JA
Circ Res; 1993 May; 72(5):958-65. PubMed ID: 8477529
[TBL] [Abstract][Full Text] [Related]
6. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets.
Mayeux PR; Morinelli TA; Williams TC; Hazard ES; Mais DE; Oatis JE; Baron DA; Halushka PV
J Biol Chem; 1991 Jul; 266(21):13752-8. PubMed ID: 1830308
[TBL] [Abstract][Full Text] [Related]
8. Specific receptors for thromboxane A2 in cultured vascular smooth muscle cells of rat aorta.
Hanasaki K; Nakano K; Kasai H; Arita H; Ohtani K; Doteuchi M
Biochem Biophys Res Commun; 1988 Feb; 150(3):1170-5. PubMed ID: 2963633
[TBL] [Abstract][Full Text] [Related]
9. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
Karasawa A; Shirakura S; Higo K; Kubo K
Arzneimittelforschung; 1991 Dec; 41(12):1237-41. PubMed ID: 1815522
[TBL] [Abstract][Full Text] [Related]
10. Characterization of thromboxane A2/prostaglandin H2 receptors in porcine coronary artery--the inhibitory effect of a novel dibenzoxepin derivative, KW-3635.
Miki I; Ishii A
Thromb Haemost; 1992 May; 67(5):582-4. PubMed ID: 1387741
[TBL] [Abstract][Full Text] [Related]
11. Biochemical characterization and comparison of rat thromboxane A2/prostaglandin H2 receptors in platelets and cultured aortic smooth muscle cells.
Hanasaki K; Nakano K; Kasai H; Arita H
Biochem Pharmacol; 1989 Sep; 38(18):2967-76. PubMed ID: 2528958
[TBL] [Abstract][Full Text] [Related]
12. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
Okwu AK; Mais DE; Halushka PV
Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
[TBL] [Abstract][Full Text] [Related]
13. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
Masuda A; Mais DE; Oatis JE; Halushka PV
Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
[TBL] [Abstract][Full Text] [Related]
14. Cultured human vascular smooth muscle cells with functional thromboxane A2 receptors: measurement of U46619-induced 45calcium efflux.
Dorn GW; Sens D; Chaikhouni A; Mais D; Halushka PV
Circ Res; 1987 Jun; 60(6):952-6. PubMed ID: 2954721
[TBL] [Abstract][Full Text] [Related]
15. A common binding site for primary prostanoids in vascular smooth muscles: a definitive discrimination of the binding for thromboxane A2/prostaglandin H2 receptor agonist from its antagonist.
Hanasaki K; Arita H
Biochim Biophys Acta; 1989 Sep; 1013(1):28-35. PubMed ID: 2528990
[TBL] [Abstract][Full Text] [Related]
16. Characterization of binding of a specific antagonist, [3H]-SQ 29,548, to soluble thromboxane A2/prostaglandin H2 (TP) receptors in human platelet membranes.
Monshizadegan H; Hedberg A; Webb ML
Life Sci; 1992; 51(6):431-7. PubMed ID: 1386132
[TBL] [Abstract][Full Text] [Related]
17. Receptor-mediated mitogenic effect of thromboxane A2 in vascular smooth muscle cells.
Hanasaki K; Nakano T; Arita H
Biochem Pharmacol; 1990 Dec; 40(11):2535-42. PubMed ID: 2148480
[TBL] [Abstract][Full Text] [Related]
18. Comparison of vascular and platelet thromboxane A2/prostaglandin H2 receptors in the pig.
Mihara S; Hara S; Ueda M; Ide M; Fujimoto M
Eur J Pharmacol; 1989 Feb; 160(3):313-21. PubMed ID: 2523812
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo.
Bertolino F; Valentin JP; Maffre M; Grelac F; Bessac AM; Maclouf J; Delhon A; Lévy-Toledano S; Patoiseau JF; Colpaert FC
Br J Pharmacol; 1995 May; 115(1):210-6. PubMed ID: 7647979
[TBL] [Abstract][Full Text] [Related]
20. Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranes.
Parent CA; Lagarde M; Venton DL; Le Breton GC
J Biol Chem; 1992 Apr; 267(10):6541-7. PubMed ID: 1532390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
